LBL-024 / Leads Biolabs 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LBL-024 / Leads Biolabs
NCT06157827: A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma

Recruiting
1/2
178
RoW
LBL-024 for Injection, LBL-024, Etoposide Injection, Etoposide, Carboplatin Injection, Carboplatin, Atezolizumab injection, Atezolizumab, Cisplatin injection, Cisplatin
Nanjing Leads Biolabs Co.,Ltd
Advanced Neuroendocrine Carcinoma
11/26
07/27
LBL-024-CN001, NCT05170958: A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Recruiting
1/2
396
RoW
LBL-024 for Injection, LBL-024
Nanjing Leads Biolabs Co.,Ltd
Advanced Solid Tumor
12/26
12/26

Download Options